Advanced Research in Pediatric Oncology
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Pediatrics".
Deadline for manuscript submissions: 10 September 2026 | Viewed by 584
Special Issue Editor
2. Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
Interests: pediatric surgical oncology; multi-omics in pediatric solid tumors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
There has been remarkable progress in pediatric oncology, yet complex challenges persist, such as effectively treating aggressive childhood cancers, minimizing long-term sequelae, and understanding disease recurrence. This Special Issue will showcase a collection of groundbreaking research articles that push the boundaries of current knowledge and therapeutic strategies. We aim to highlight cutting-edge advancements across the spectrum of pediatric cancer research. We invite submissions utilizing multi-omics approaches (genomics, transcriptomics, proteomics, and metabolomics) to decipher tumor heterogeneity and identify novel vulnerabilities. Contributions exploring advanced diagnostics, innovative targeted therapies, next-generation immunotherapies, precision medicine frameworks, and the intricate biology of the tumor microenvironment are particularly encouraged. This Special Issue will also cover the application of artificial intelligence, novel drug delivery systems, and strategies to improve long-term survivorship and quality of life, working toward a future where there are more effective and less toxic treatments for children with cancer.
Prof. Dr. Surasak Sangkhathat
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatric oncology
- multi-omics
- precision medicine
- targeted therapy
- advanced diagnostics
- tumor microenvironment
- single-cell biology
- drug discovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
